您的位置: 首页 > 农业专利 > 详情页

THERAPEUTIC VARIANT ALPHA-2-MACROGLOBULIN COMPOSTIONS
专利权人:
CYTONICS CORPORATION
发明人:
Lewis HANNA,John David LAUGHLIN,Shawn Robert BROWNING
申请号:
US15528387
公开号:
US20170355749A1
申请日:
2015.11.20
申请国别(地区):
US
年份:
2017
代理人:
摘要:
A2M polypeptide compositions containing a non-natural bait region are disclosed. Methods of producing wild-type and variant A2M polypeptides and polynucleotides containing a non-natural bait region are also disclosed. The bait regions of the variant A2M polypeptides demonstrate enhanced protease inhibitory characteristics compared to wild-type A2M. Variant A2M polypeptides that demonstrate longer half-lives upon administration to an organism compared to wild-type A2M are disclosed. The A2M compositions are useful in treating a number of diseases and conditions including inflammation, chronic wounds, and diseases with a pathology associated with proteases.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充